4. Vaccine is a biological preparation that
provides active acquired immunity to a
particular disease.
Vaccine is a suspension of organism that is
used to induced immunity.
5. Vaccine are produced in large scale as
they need to be administered to large
population of children and adults to be
effective as public health tool.
To synthesize a live attenuated vaccine the
disease causing organisms is grown under
laboratory conditions that cause to lose its
disease causing properties.
6. The attenuated can be obtained by heat or by
passage of the virus in foreign host such as
embryonated eggs & tissue culture cells.
Cell culture required for viral vaccine since
virus can replicate inside the living cells.
e.g. to produce Sabin polio vaccine
attenuated was only achieved with high
inocula and rapid passage in primary monkey
kidney cells.
7. 1- Generation of the antigen
2-Release and isolation of the antigen
3-Purification
4-Addition of other components
5-Packaging
8. For this purpose the pathogen’s protein and
DNA need to be grown & harvested using the
following mechanism:
Viruses are grown on primary cells such as
cell from chicken embryos or using fertilised
eggs or cell line.
Bacteria are grown in bioreactors.
Recombinant proteins derived from the
pathogens can be generated in yeast,
bacteria or cell culture.
9. The aim of this is to release as much
viruses or bacteria as possible.
To achieve this the antigen will be
separated from the cell & isolate from the
protein & other parts of the growth medium
that are still present.
10. The antigen will need to be purified in
order to produce high quality product.
For weakened or attenuated viruses no
further purification may required.
Recombinant protein may need many
operations involving ultra filtration &
column chromatography for purification
before they are ready for administration.
11. Once the antigen is developed the vaccine
is formulated by adding adjutants stabilizer
& preservatives.
Adjutants enhance the immune response
of the antigen.
Stabilizer increase the storage life.
Preservatives allow the use of multi dose
vials.
12. The product need to be protected from air,
water and human contamination.
The environment need to be protected
from spillage of the antigens.
13. Once the vaccine is put in the recipient
vessels it is sealed with sterile stoppers.
GMPs will involve several quality controls
and an adequate infrastructure and
separation of activities to avoid cross
contamination.
Finally the vaccine is labeled and
distributed worldwide.